Merus B.V. IPO Research Information

Merus B.V. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Merus B.V., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Merus B.V.	MRUS - NASDAQ	$14.00-$16.00	$10.00	$9.75	5.5 million	5/19/2016
Underwriter(s): Citigroup, Jefferies
Co-Manager(s): Guggenheim Securities, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2015-10-19 Terms Added 2016-05-09

Merus B.V. Quote & Chart - Click for current quote - MRUS

About Merus B.V. (adapted from Merus B.V. prospectus):
They are a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MRUS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.